Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Theodorescu

Showing results (51-60 of 275) with videos related to

Pageof 28
Sort By:
BJU International|August 27, 2004
Health-related quality of life after prostate brachytherapyNicole L Miller, Dan Theodorescu
European Journal of Cancer (Oxford, England : 1990)|March 30, 2010
RhoGDI signaling provides targets for cancer therapyMichael A Harding, Dan Theodorescu
The Journal of Urology|September 28, 2002
Morbidity of modified prophylactic inguinal lymphadenectomy for squamous cell carcinoma of the penisTimothy R Coblentz, Dan Theodorescu
Nature Reviews. Urology|December 22, 2011
Bladder cancer in 2011: the dawn of personalized medicineThomas W Flaig, Dan Theodorescu
Urologic Oncology|April 11, 2012
Perspectives on personalized cancer careGarrett M Dancika, Dan Theodorescu
Nature Clinical Practice. Oncology|February 7, 2008
Metastasis: a therapeutic target for cancerPatricia S Steeg, Dan Theodorescu
Plos One|January 28, 2014
Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genesGarrett M Dancik, Dan Theodorescu
Cancer Metastasis Reviews|June 22, 2012
The faces and friends of RhoGDI2Erin M Griner, Dan Theodorescu
European Urology|January 22, 2019
Re: Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant ChemotherapyTahlita C M Zuiverloon, Dan Theodorescu
World Journal of Urology|August 16, 2003
Permanent interstitial brachytherapy for prostate cancer: a current reviewJeffrey Woolsey, Nicole Miller, Dan Theodorescu
Pageof 28

Showing results (51-60 of 275) with videos related to

Sort By:
Pageof 28
BJU International|August 27, 2004
Health-related quality of life after prostate brachytherapyNicole L Miller, Dan Theodorescu
European Journal of Cancer (Oxford, England : 1990)|March 30, 2010
RhoGDI signaling provides targets for cancer therapyMichael A Harding, Dan Theodorescu
The Journal of Urology|September 28, 2002
Morbidity of modified prophylactic inguinal lymphadenectomy for squamous cell carcinoma of the penisTimothy R Coblentz, Dan Theodorescu
Nature Reviews. Urology|December 22, 2011
Bladder cancer in 2011: the dawn of personalized medicineThomas W Flaig, Dan Theodorescu
Urologic Oncology|April 11, 2012
Perspectives on personalized cancer careGarrett M Dancika, Dan Theodorescu
Nature Clinical Practice. Oncology|February 7, 2008
Metastasis: a therapeutic target for cancerPatricia S Steeg, Dan Theodorescu
Plos One|January 28, 2014
Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genesGarrett M Dancik, Dan Theodorescu
Cancer Metastasis Reviews|June 22, 2012
The faces and friends of RhoGDI2Erin M Griner, Dan Theodorescu
European Urology|January 22, 2019
Re: Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant ChemotherapyTahlita C M Zuiverloon, Dan Theodorescu
World Journal of Urology|August 16, 2003
Permanent interstitial brachytherapy for prostate cancer: a current reviewJeffrey Woolsey, Nicole Miller, Dan Theodorescu
Pageof 28